5:30 PM
 | 
Apr 28, 2014
 |  BC Extra  |  Company News

Forest to acquire Furiex

Forest Laboratories Inc. (NYSE:FRX) will acquire Furiex Pharmaceuticals Inc. (NASDAQ:FURX) for $95 per share in cash, or about $1.1 billion, plus a contingent value right worth up to $30 per share, or up to $360 million, tied to approval and scheduling by the U.S. Drug Enforcement Agency...

Read the full 224 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >